Scientific Innovation

Externally Sponsored Research (ESR)

What is Externally Sponsored Research (ESR)?

 

We believe in accelerating discovery processes to bring solutions to patients through innovative and collaborative science-driven research.


Externally Sponsored Research (ESR) can lead to meaningful advances in disease understanding and treatment.

Investigator-Initiated-Studies

Investigator-Initiated Studies (IIS)

Research that is conducted by an external third party who assumes regulatory and legal responsibility for development, conduct, and oversight of the study. argenx supports Investigator-Initiated Studies, which may be interventional or observational.

Clinical Research Collaboration

Clinical Research Collaboration

Clinical Research Collaboration is similar to IIS research in that the external third party assumes regulatory and legal responsibility for development, conduct, and oversight of the study. Unlike with IIS, argenx can initiate research and collaborate with investigators in service of developing and executing innovative study designs and move the science forward together.

Email esr@argenx.com to learn more.

Inquiries and research proposals that are not ESRs can be sent to BD@argenx.com.

Our principles

Patient-focused

Patient-focused

Everything we do should improve the lives of patients and caregivers. 

 

Impactful

Impactful

Our science and research efforts should seek to deliver real world impact for both physicians and patients.

Ethical

Ethical

We adhere to a strict ethical standard and only look to collaborate with those who prioritize transparency and compliance.

Frontier Science

Frontier science

argenx wants to deliver new and novel therapies that disrupt long-standing gaps in the standard of care.

Areas Of interest

Areas of interest

Innovation is a principal tenet of argenx, which drives us to unearth critical breakthroughs in immunology medicine with every step we take towards improving patient outcomes.

argenx values open collaboration and partnership in the spirit of creating novel therapies and treatment options. As part of this commitment, argenx will consider proposals within a wide range of focus.


To learn about our current areas of interest in detail, please download our Investigator-Initiated Studies Guide or submit an inquiry at esr@argenx.com or fill out the form below.

Have Questions?

Want to get in contact with us?

Please fill out the form below, tell us how we can help, and we will get in touch with you shortly by email or phone.

Required items marked with an asterisk *

I understand that I may withdraw my authorization provided above by emailing privacy@argenx.com or following the unsubscribe instructions on the communication. Unless I withdraw this authorization, it will remain effective for 5 years. Copies of this authorization may be obtained by emailing privacy@argenx.com. Please read the argenx Privacy Policy for additional information.

By completing this form and clicking submit, you are confirming that your inquiry is unsolicited and consenting to have your information be used to process your request. Your information will be retained within a secure environment at argenx. 

argenx Policy on Submission of a Research Proposal:

  • All material submitted is non-confidential and does not contain any markings claiming confidentiality. By submitting your materials to argenx for review, you understand that we will not treat the information as confidential or proprietary. It is necessary to refer a submission to a number of different persons in the Company to ascertain whether or not a research proposal is of interest. Thus, while we have no intention of publicizing a submission, we can assume no obligation to keep it confidential.        
  • It is our policy to consider research proposals from persons outside the Company upon the following conditions:
    • That the submission is not made in confidence and is not accompanied by any reservation or condition which imposes upon argenx any obligation or restriction with regard to its use.
    • That the submitter's rights shall be only those given under the patent laws and/or under any written contract to which the submitter and argenx may mutually agree.
    • That the submitter is the originator of the information and materials or has been authorized by the originator to provide information and materials on their behalf

Thank you for your interest.

You should receive a confirmation email from us shortly. In the meantime, you can download the Investigator-Initiated Studies Guide for more information about IIS Proposals.